If left unchecked, this side effect can derail your health goals and disrupt your daily life
Certain supplements can interfere with medications or exacerbate health issues
E., Lee, C
BioWorld - Tuesday, July 28, 2026 See today's BioWorld Home Pfizer M&A prospect Metsera heads to phase III with lead GLP-1 Phase IIb data of Metsera Inc.s lead GLP-1 receptor agonist, MET-097i, showed significant weight loss and good tolerability, supporting a phase III start later this year, and validating Pfizer Inc.s decision a week ago to buy the obesity-focused company for $7.3 billion
Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Market Report Scope Source: Polaris Market Research Analysis GLP-1 Market FAQ's The GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034
Consider your caffeine intake, as changes in eating patterns during the transition may inadvertently reduce your usual caffeine consumption, triggering withdrawal headaches
